Status:
ACTIVE_NOT_RECRUITING
Brigham and Women's Rheumatoid Arthritis Sequential Study
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Crescendo Bioscience
Bristol-Myers Squibb
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
The goal of the present study is to establish a prospective observational cohort of Rheumatoid Arthritis patients in order to 1. Determine and validate biomarkers that predict drug response and toxic...
Detailed Description
The Registry will be a prospective observational study totaling 1600 patients diagnosed with RA. Patients who are 18 years of age or greater, are a patient at the R.B. Brigham Arthritis Center and hav...
Eligibility Criteria
Inclusion
- Are 18 years of age or older;
- Are a patient registered at the R.B.Brigham Arthritis Center.
- Have, at the time of enrollment a diagnosis of RA made by a board certified rheumatologist.
- Are able and willing to provide informed consent.
Exclusion
- less than 18 years of age
- do not have a diagnosis of RA
- have a history of SLE or Psoriasis
Key Trial Info
Start Date :
March 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2028
Estimated Enrollment :
1598 Patients enrolled
Trial Details
Trial ID
NCT01793103
Start Date
March 1 2003
End Date
March 1 2028
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115